Delivery Order SPE2DB20D1100-SPE2DB24FC8K1
Award Date
7/19/24
Potential Completion Date
7/22/24
Potential Value
$9.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,080.33, is for the delivery of ONTRUZANT 150 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of ONTRUZANT 150 MG vials. The contract has a completion date of March 4, 2024 and a potential value of $21,941.07. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of ONTRUZANT 150 MG VIALS, a pharmaceutical product, with a performance period through March 7, 2024 and a potential value of $38,952.93. This order is issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA, which serves as the primary...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ONTRUZANT 150 MG vials, with a completion date of March 6, 2024 and a potential value of $1,436.46. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and has...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $5,621.75 firm fixed-price contract is for the delivery of ONTRUZANT 150 MG VIALS, a pharmaceutical product, with a performance period through May 12, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $62,776.72 contract is for the delivery of 4,565,631,436 vials of the pharmaceutical product ONTRUZANT 420 MG. The order has an ultimate completion date of August 30, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the federal government, was awarded this delivery order through the company's Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of ONTRUZANT 150 MG VIALS. The contract has a ceiling value of $4,354.03 and is a firm fixed price delivery order. The contract has a period of performance through July 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for delivering a comprehensive...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution and services company. The contract is for the delivery of 150 mg vials of the pharmaceutical product ONTRUZANT, with a ceiling value of $16,458.59 and a completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor for this award,...
This federal contract award, valued at $4,348.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ONTRUZANT 420 MG VIALS, a pharmaceutical product, with a completion date of May 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $11,422.97 firm fixed price contract is for the delivery of ONTRUZANT 150 MG VIALS. This order does not have a set-aside designation and is scheduled for completion by January 4, 2024. Amerisourcebergen Drug Corp has...